Potentially hepatotoxic drugs are still being prescribed to liver disease patients under tertiary care: it is time to say enough

• Main Authors: Rodrigo Dorelo (Author), Samantha T.A. Barcelos (Author), Magela Barros (Author), Valeria Elustondo (Author), Ysela Y.P. Pérez (Author), Martin Oricchio (Author), Nelson D.S. Uribe (Author), Nelia Hernandez (Author), Dvora Joveleviths (Author), Mario R. Alvares- (Author)
• Format: Book
• Published: Universidad Nacional Hermilio Valdizán, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction and aim: Drug-induced liver injury (DILI) manifests as a spectrum of clinical presentations that carries morbidity and mortality. Patients with chronic liver disease (CLD), particularly hospitalized, are at high risk for developing DILI. We aimed to investigate the use of potentially he...